Risk assessment of acute vascular events in congenital disorder of glycosylation type Ia.

[1]  N. Akar,et al.  High plasma levels of factor VIII: An important risk factor for isolated pulmonary embolism , 2006, Respirology.

[2]  S. Opal,et al.  Coagulation in sepsis , 2004, Intensive Care Medicine.

[3]  E. Minar,et al.  Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism. , 2004, Blood.

[4]  T. van der Poll,et al.  Sepsis and Disseminated Intravascular Coagulation , 2003, Journal of Thrombosis and Thrombolysis.

[5]  G. Matthijs,et al.  Neurological presentation in pediatric patients with congenital disorders of glycosylation type Ia. , 2003, Neuropediatrics.

[6]  M. Hoylaerts,et al.  Congenital disorders of glycosylation type Ia and IIa are associated with different primary haemostatic complications , 2001, Journal of Inherited Metabolic Disease.

[7]  D. Krasnewich,et al.  Neurologic Course of Congenital Disorders of Glycosylation , 2001, Journal of child neurology.

[8]  M. Pineda,et al.  Congenital disorders of glycosylation (CDG) may be underdiagnosed when mimicking mitochondrial disease. , 2001, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[9]  A. Munnich,et al.  A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases , 2001, Journal of medical genetics.

[10]  V. Drouin‐Garraud,et al.  Neurological presentation of a congenital disorder of glycosylation CDG-Ia: implications for diagnosis and genetic counseling. , 2000, American journal of medical genetics.

[11]  F. Rosendaal,et al.  High levels of factor IX increase the risk of venous thrombosis. , 2000, Blood.

[12]  P. Clayton,et al.  Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type 1 , 2000, Journal of Inherited Metabolic Disease.

[13]  P. Vreken,et al.  Carbohydrate-deficient glycoprotein syndrome type 1a: a variant phenotype with borderline cognitive dysfunction, cerebellar hypoplasia, and coagulation disturbances. , 2000, The Journal of pediatrics.

[14]  G. Young,et al.  Coagulation abnormalities in the carbohydrate‐deficient glycoprotein syndrome: Case report and review of the literature , 1999, American journal of hematology.

[15]  J. Jaeken,et al.  Haemostatic Studies in Carbohydrate-deficient Glycoprotein Syndrome Type I , 1996, Thrombosis and Haemostasis.

[16]  L. Tengborn,et al.  Complex functional and structural coagulation abnormalities in the carbohydrate‐deficient glycoprotein syndrome type I , 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[17]  C. Chopin,et al.  Coagulation inhibitor substitution during sepsis , 1995, Intensive Care Medicine.

[18]  W. Kreuz,et al.  Thrombophilia in a Child with CDG-Syndrome Type I , 1995, Thrombosis and Haemostasis.

[19]  K. Takeshita,et al.  Neuroradiological findings in the carbohydrate-deficient glycoprotein syndrome , 1995, Neuroradiology.

[20]  K. Takeshita,et al.  Hemostatic studies in patients with carbohydrate-deficient glycoprotein syndrome. , 1994, Thrombosis research.

[21]  B. Hagberg,et al.  Carbohydrate-deficient glycoprotein syndrome: clinical expression in adults with a new metabolic disease. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[22]  J. Jaeken,et al.  A Unique Pattern of Coagulation Abnormalities in Carbohydrate-Deficient Glycoprotein Syndrome , 1993, Pediatric Research.

[23]  Y. Wada,et al.  Decreased blood coagulation activities in carbohydrate-deficient glycoprotein syndrome , 1993, Journal of Inherited Metabolic Disease.

[24]  B. Ehinger,et al.  Full-field electroretinograms in patients with the carbohydrate-deficient glycoprotein syndrome. , 1991, American journal of ophthalmology.

[25]  J. Walls,et al.  Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin. , 1991, The Journal of biological chemistry.

[26]  L. Wiklund,et al.  Neurological Findings in the Carbohydrate‐deficient Glycoprotein Syndrome , 1991 .

[27]  A. Torvik,et al.  Postmortem Findings in Two Patients with the Carbohydrate‐deficient Glycoprotein Syndrome , 1991 .

[28]  J. Jaeken,et al.  Clinical Presentation and Natural Course of the Carbohydrate‐deficient Glycoprotein Syndrome , 1991 .

[29]  C. Nordborg,et al.  Sural Nerve Pathology in the Carbohydrate‐deficient Glycoprotein Syndrome , 1991 .

[30]  M. Blombäck,et al.  Protein C, Protein S and c4b-Binding Protein in Severe lnfection and Septic Shock , 1991, Thrombosis and Haemostasis.

[31]  J. T. ten Cate,et al.  The function of the human factor V carbohydrate moiety in blood coagulation. , 1987, European journal of biochemistry.

[32]  J. Jaeken,et al.  Familial psychomotor retardation with markedly fluctuating serum prolactin, FSH and GH levels, partial TBG-deficiency, increased serum arylsulphatase A and increased CSF protein: a new syndrome?: 90 , 1980, Pediatric Research.

[33]  J. Jaeken,et al.  Carbohydrate-deficient glycoconjugate (CDG) syndromes: a new chapter of neuropaediatrics. , 1997, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[34]  F. Skovby,et al.  Early manifestations of the carbohydrate-deficient glycoprotein syndrome. , 1993, The Journal of pediatrics.

[35]  K. Strömland,et al.  Ocular pathology in disialotransferrin developmental deficiency syndrome. , 1990, Ophthalmic paediatrics and genetics.